Clinical Trial: A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734493) titled 'A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia' on July 20.

Brief Summary: The purpose of this clinical trial is to learn whether the investigational drug LTX-001 is safe and well tolerated in adults with a diagnosis of schizophrenia who are having a recent worsening of their symptoms (an acute exacerbation). Additional questions it aims to answer are:

* how does the amount of the study drug in the body change over time (pharmacokinetics)

* how does the study drug affect the symptoms of schizophrenia

* how do certain markers in the blood change after administration of LTX-001 (pharmacodynamics)...